Newfeed

NANJING, China, June 17, 2024 /PRNewswire/ — At the recent European League Against Rheumatism (EULAR) Congress in Vienna, Austria, Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) delivered an oral presentation on its highly innovative therapeutic candidate LBL-047. LBL-047 is a first-in-class,

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: